NewslettersNeural Cell News Rezolute to Initiate a Pivotal Phase III Study of RZ358 in Participants 3 Months of Age and Older with Congenital Hyperinsulinism By Jamie Kang - June 28, 2023 0 Rezolute, Inc. plans to initiate sunRIZE, a pivotal Phase II clinical study of RZ358, in Europe and other geographies outside the US in Q4 2023. [Rezolute, Inc.] Press Release